Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Regulatory News In Brief

This article was originally published in The Gray Sheet

Executive Summary

J&J's Sedasys appeal docket

You may also be interested in...



New Year, New Staffers: CDRH Announces Key Personnel Changes

CDRH’s Office of Device Evaluation creates a chief medical officer role to improve consistency in clinical policy, among other recent staffing changes.

FDA Kicks Off 510(k) Reform Plan, Punts Some Decisions To IOM

FDA’s plan for improving its 510(k) pre-market submission program includes clarifying instances where clinical data should be included and streamlining its “de novo” review process for certain innovative, lower-risk devices.

J&J Gets Second Chance At Sedasys Sedation Device Approval

Johnson & Johnson subsidiary Ethicon Endo-Surgery has received a go-ahead from the FDA commissioner's office to embark on a rarely used process to appeal a PMA denial by the agency’s device center.

Related Content

Topics

UsernamePublicRestriction

Register

LL010986

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel